SRRKScholar Rock Holding Corporation

SRRK Stock Price, Valuation & Chart | Scholar Rock Holding Corporation

Compare

$56.500+1.25 (+2.26%)

At close · 21 Aug 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology SRRK intrinsic value Is SRRK overvalued or undervalued

Overview Financials Dividends Ratios

SRRK Historical price chart

SRRK Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization6.77B

PE Ratio-16.38

EPS-3.45

Trading Volume1.13M

Today's High/Low57.09/54.98

Dividend Yield0.00

52 Week High/Low58.49/27.07

Shares Outstanding119.83M

SRRK Financial Statement

SRRK Analyst ratings

SRRK Analysis & performance metrics

SRRK Company profile

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling…

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal…

SRRK Management team

Name

Position

Erin Moore CPA

Interim Principal Financial & Accounting Officer

Robert Keith WoodsCOO

Chief Operating Officer

Jing L. Marantz M.B.A., M.D., Ph.D.

Chief Medical Officer

Mo Qatanani Ph.D.

Chief Scientific Officer

David L. HallalCEO

Chief Executive Officer & Chairman of the Board

Vikas Sinha C.A., CPA, M.B.A.CFO

Chief Financial Officer

Caryn Parlavecchio

Chief Human Resources Officer

Akshay K. Vaishnaw M.D., Ph.D.CTO

President of R&D, Member of Scientific Advisory Board and Director

Name

Position

Erin Moore CPA

Interim Principal Financial & Accounting Officer

Robert Keith WoodsCOO

Chief Operating Officer

Jing L. Marantz M.B.A., M.D., Ph.D.

Chief Medical Officer

Mo Qatanani Ph.D.

Chief Scientific Officer

David L. HallalCEO

Chief Executive Officer & Chairman of the Board

Vikas Sinha C.A., CPA, M.B.A.CFO

Chief Financial Officer

Caryn Parlavecchio

Chief Human Resources Officer

Akshay K. Vaishnaw M.D., Ph.D.CTO

President of R&D, Member of Scientific Advisory Board and Director

Management Team

Erin Moore CPA

Interim Principal Financial & Accounting Officer

Robert Keith WoodsCOO

Chief Operating Officer

Jing L. Marantz M.B.A., M.D., Ph.D.

Chief Medical Officer

Mo Qatanani Ph.D.

Chief Scientific Officer

David L. HallalCEO

Chief Executive Officer & Chairman of the Board

Vikas Sinha C.A., CPA, M.B.A.CFO

Chief Financial Officer

Caryn Parlavecchio

Chief Human Resources Officer

Akshay K. Vaishnaw M.D., Ph.D.CTO

President of R&D, Member of Scientific Advisory Board and Director

Management

Erin Moore CPA

Interim Principal Financial & Accounting Officer

Robert Keith WoodsCOO

Chief Operating Officer

Jing L. Marantz M.B.A., M.D., Ph.D.

Chief Medical Officer

Mo Qatanani Ph.D.

Chief Scientific Officer

David L. HallalCEO

Chief Executive Officer & Chairman of the Board

Vikas Sinha C.A., CPA, M.B.A.CFO

Chief Financial Officer

Caryn Parlavecchio

Chief Human Resources Officer

Akshay K. Vaishnaw M.D., Ph.D.CTO

President of R&D, Member of Scientific Advisory Board and Director

Total 8 executives

SRRK Frequently asked questions

What is Scholar Rock Holding Corporation (SRRK) Stock Price?

Current stock price of Scholar Rock Holding Corporation (SRRK) stock is $56.500. The stock price is +2.26% higher in the session. The intraday range can be seen from this page. Volume of Scholar Rock Holding Corporation (SRRK) stock is 1.13M.

Last updated at 21 Aug 2026, 08:00 pm.

Why is the Scholar Rock Holding Corporation (SRRK) stock price going up or down today?

The stock price of Scholar Rock Holding Corporation (SRRK) can change with earnings, company news, and overall market sentiment. Scholar Rock Holding Corporation operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Scholar Rock Holding Corporation stock expensive at its current price?

Whether Scholar Rock Holding Corporation looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SRRK on this page is -16.38. EPS on this page is -3.45. Compare those figures with peers and growth expectations before deciding if the current Scholar Rock Holding Corporation price is justified.

How has the stock price of Scholar Rock Holding Corporation (SRRK) performed historically?

Historical performance for Scholar Rock Holding Corporation (SRRK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SRRK reacted to past earnings and market events.

Should I buy Scholar Rock Holding Corporation (SRRK) stock, at this price?

Buying Scholar Rock Holding Corporation (SRRK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.